Imron T. Aly is a trial lawyer who serves as lead counsel for clients on dozens of matters, and has first-chaired more than 10 trials. Imron is co-leader of Schiff Hardin’s Intellectual Property Group and co-chair of the firm’s Hatch-Waxman and Biosimilars patent litigation team.
His practice is focused on patent infringement litigation. He has litigated and tried patent infringement and other IP matters related to pharmaceuticals, medical implants and devices, DNA arrays, mechanical production assemblies, computer business methods, and financial trading systems.
Clients and leading industry publications describe Imron as a prepared courtroom advocate whose “tenacity sets him apart,” who “stands out for his pure advocacy skills,” and “is an untiring advocate for his clients’ cause.”
Prior to joining Schiff Hardin, Imron was an intellectual property partner in the Chicago office of an international law firm.
Fresenius Kabi USA, LLC v. FERA Pharmaceuticals, LLC (Successfully represented Fresenius Kabi USA, LLC in obtaining a rare preliminary injunction in federal district court. The injunction barred our client’s competitor from launching a generic version of its patented formulation of levothyroxine, an injectable thyroid hormone. The District Court for the District of New Jersey granted the injunction on the basis that our client was likely to win its patent lawsuit against its competitor.)
- Georgetown University Law Center, J.D., 1999
- Duke University, B.S.E., 1996
- U.S. Patent and Trademark Office
- Richard Linn American Inn of Court
Rate : $$$